Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles.

MLA

Osorio, Ana, et al. “Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles.” Human Mutation, vol. 34, no. 12, Dec. 2013, pp. 1615–18. EBSCOhost, https://doi.org/10.1002/humu.22438.

APA

Osorio, A., Bogliolo, M., Fernández, V., Barroso, A., de la Hoya, M., Caldés, T., Lasa, A., Ramón y Cajal, T., Santamariña, M., Vega, A., Quiles, F., Lázaro, C., Díez, O., Fernández, D., González-Sarmiento, R., Durán, M., Piqueras, J. F., Marín, M., Pujol, R., … Benítez, J. (2013). Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles. Human Mutation, 34(12), 1615–1618. https://doi.org/10.1002/humu.22438

Chicago

Osorio, Ana, Massimo Bogliolo, Victoria Fernández, Alicia Barroso, Miguel de la Hoya, Trinidad Caldés, Adriana Lasa, et al. 2013. “Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles.” Human Mutation 34 (12): 1615–18. doi:10.1002/humu.22438.